Clinical Trials Browser

Glioma

NCT00404248 2019-03-06

Tetra-O-Methyl Nordihydroguaiaretic Acid in Treating Patients With Recurrent High-Grade Glioma

Phase 1/2 Completed

35 enrolled 13 charts

CNSSarcoma

Astrocytoma, Brain Neoplasms, Glioblastoma, Oligodendroglioma, Central Nervous System Neoplasms, Gliosarcoma

NCT00057512 2016-02-23

Study of Intralesional Injection of M4N in Patients With Refractory Malignant Tumors of the Head and Neck

Phase 1 Completed

9 enrolled

Head & Neck

Head and Neck Neoplasms

NCT00664677 2016-02-23

Phase 1 Study of Terameprocol (EM-1421) in Patients With Leukemia

Phase 1 Terminated

16 enrolled

LymphoidMyeloidOther hematologic neoplasm

Leukemia, Myelodysplastic Syndromes, Leukemia, Lymphocytic, Chronic, B-Cell, Leukemia, Myelogenous, Chronic, BCR-ABL Positive, Leukemia, Myeloid, Acute, Leukemia, Myelomonocytic, Chronic, Precursor Cell Lymphoblastic Leukemia-Lymphoma, Precursor T-Cell Lymphoblastic Leukemia-Lymphoma

NCT00259818 2008-01-24

Dose Escalation Study of EM-1421 for the Treatment of Recurrent or Refractory Solid Tumors

Phase 1 Completed

30 enrolled

Tumor-Agnostic

Neoplasms

Clinical Trials

Terameprocol in Treating Patients With Recurrent High Grade Glioma

Tetra-O-Methyl Nordihydroguaiaretic Acid in Treating Patients With Recurrent High-Grade Glioma

Study of Intralesional Injection of M4N in Patients With Refractory Malignant Tumors of the Head and Neck

Phase 1 Study of Terameprocol (EM-1421) in Patients With Leukemia

Dose Escalation Study of EM-1421 for the Treatment of Recurrent or Refractory Solid Tumors